Annual Epidemiological Report 2009 [2007 data]
This edition of the Annual Report gives special attention to vaccine-preventable diseases and immunisation programmesin the European Union (EU) and European Economic Area (EEA) countries. This edition was revised January and June 2010 and has authority over the print edition.
- Antimicrobial resistance
- Avian influenza virus
- Emerging disease
- Food- and waterborne diseases
- Healthcare-associated infections
- HIV infection
- Influenza in humans, avian origin
- Influenza in humans, seasonal
- Sexually transmitted infections
- Vaccine preventable diseases
- Vector-borne disease
Yersiniosis - Annual Epidemiological Report for 2016
In 2016, 28 countries reported 6 918 confirmed yersiniosis cases in the EU/EEA.
Anthrax - Annual Epidemiological Report for 2016
Anthrax continues to be a rare disease in humans in Europe, with only a few cases reported every year. In 2016, two EU/EEA countries reported six laboratory-confirmed anthrax cases: Romania (5) and Spain (1). The remaining 28 reporting countries notified no cases.
Congenital toxoplasmosis – Annual Epidemiological Report for 2016
In 2016, 242 confirmed cases of congenital toxoplasmosis were reported in the EU/EEA, with France accounting for 81% of all confirmed cases due to the active screening of pregnant women. The notification rate was 6.7 cases per 100 000 live births. No seasonal pattern was observed for the disease.
Tularaemia - Annual Epidemiological Report for 2016
For 2016, 1 148 cases of tularaemia were reported in the EU/EEA, 1 096 (95%) of which were confirmed.
Leptospirosis - Annual Epidemiological Report 2016 [2014 data]
Annual Epidemiological Report for leptospirosis 2016. ECDC’s annual surveillance reports provide a wealth of epidemiological data to support decision-making at the national level. They are mainly intended for public health professionals and policymakers involved in disease prevention and control programmes.
Campylobacteriosis - Annual Epidemiological Report for 2016
Campylobacteriosis is a very common gastrointestinal disease in the EU/EEA. In 2016, 29 EU/EEA countries reported 248 752 confirmed cases of campylobacteriosis.
Brucellosis – Annual Epidemiological Report for 2017
In 2017, 381 confirmed brucellosis cases were reported in the EU/EEA. The notification rate in the EU/EEA was 0.09 cases per 100 000 population. The highest rates were reported in southern EU Member States (Greece, Italy and Portugal). The highest rate was observed in 25–44-year-old males (0.16 per 100 000). The notification rate was stable from 2013–2017 in the EU/EEA.